13D/13G Filings - Fulcrum Therapeutics Inc. (FULC)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-13
12:08 pm
Purchase
2023-12-3113GFulcrum Therapeutics, Inc.
FULC
Suvretta Capital Management, LLC5,518,881
8.900%
1,244,078increase
(+29.10%)
Filing
History
2024-02-09
09:03 am
Purchase
2024-02-0813GFulcrum Therapeutics, Inc.
FULC
FMR LLC5,684,615
9.195%
450,890increase
(+8.62%)
Filing
History
2024-02-07
07:44 am
Sale
2023-12-3113GFulcrum Therapeutics, Inc.
FULC
ADAGE CAPITAL PARTNERS GP L.L.C.1,506,422
2.440%
-1,964,125decrease
(-56.59%)
Filing
History
2023-07-07
4:35 pm
Sale
2023-06-3013GFulcrum Therapeutics, Inc.
FULC
BlackRock Inc.
BLK
1,514,425
2.500%
-1,754,566decrease
(-53.67%)
Filing
History
2023-03-06
4:40 pm
Purchase
2023-02-2413GFulcrum Therapeutics, Inc.
FULC
ADAGE CAPITAL PARTNERS GP L.L.C.3,470,547
5.630%
2,350,547increase
(+209.87%)
Filing
History
2023-02-14
4:15 pm
Sale
2022-12-3113GFulcrum Therapeutics, Inc.
FULC
Point72 Asset Management, L.P.30,702
0.100%
-2,037,172decrease
(-98.52%)
Filing
History
2023-02-14
4:07 pm
Sale
2022-12-3113GFulcrum Therapeutics, Inc.
FULC
Third Rock Ventures III L.P.2,343,154
4.500%
-1,703,271decrease
(-42.09%)
Filing
History
2023-02-14
10:04 am
Purchase
2022-12-3113GFulcrum Therapeutics, Inc.
FULC
RTW INVESTMENTS LP4,993,279
9.600%
1,126,407increase
(+29.13%)
Filing
History
2023-02-13
10:15 am
Purchase
2022-12-3113GFulcrum Therapeutics, Inc.
FULC
Suvretta Capital Management, LLC4,274,803
8.200%
1,899,232increase
(+79.95%)
Filing
History
2023-02-09
11:39 am
Sale
2022-12-3113GFulcrum Therapeutics, Inc.
FULC
ADAGE CAPITAL PARTNERS GP L.L.C.1,120,000
2.150%
-1,030,000decrease
(-47.91%)
Filing
History
2023-02-09
10:59 am
Sale
2023-02-0913GFulcrum Therapeutics, Inc.
FULC
FMR LLC5,233,725
10.054%
-848,592decrease
(-13.95%)
Filing
History
2023-02-01
4:54 pm
Purchase
2022-12-3113GFulcrum Therapeutics, Inc.
FULC
BlackRock Inc.
BLK
3,268,991
6.300%
1,060,913increase
(+48.05%)
Filing
History
2023-01-23
3:41 pm
Sale
2022-12-3013GFulcrum Therapeutics, Inc.
FULC
Cowen Financial Products LLC1,367,759
2.615%
-729,131decrease
(-34.77%)
Filing
History
2023-01-06
4:30 pm
Purchase
2023-01-0413GFulcrum Therapeutics, Inc.
FULC
RA CAPITAL MANAGEMENT L.P.9,686,628
18.600%
2,686,628increase
(+38.38%)
Filing
History
2022-08-26
4:38 pm
Purchase
2022-08-1613GFulcrum Therapeutics, Inc.
FULC
RA CAPITAL MANAGEMENT L.P.7,000,000
13.450%
7,000,000increase
(New Position)
Filing
History
2022-06-22
4:14 pm
Purchase
2022-06-2113GFulcrum Therapeutics, Inc.
FULC
Point72 Asset Management, L.P.2,067,874
5.100%
729,206increase
(+54.47%)
Filing
History
2022-03-10
4:30 pm
Purchase
2022-02-2813GFulcrum Therapeutics, Inc.
FULC
ADAGE CAPITAL PARTNERS GP L.L.C.2,150,000
5.290%
2,150,000increase
(New Position)
Filing
History
2022-03-09
09:08 am
Purchase
2022-03-0413GFulcrum Therapeutics, Inc.
FULC
Cowen Financial Products LLC2,096,890
5.160%
2,096,890increase
(New Position)
Filing
History
2022-02-14
5:06 pm
Sale
2021-12-3113GFulcrum Therapeutics, Inc.
FULC
Third Rock Ventures III L.P.4,046,425
10.000%
-1,915,777decrease
(-32.13%)
Filing
History
2022-02-14
08:22 am
Purchase
2021-12-3113GFulcrum Therapeutics, Inc.
FULC
RTW INVESTMENTS LP3,866,872
9.500%
1,795,463increase
(+86.68%)
Filing
History
Goto Prev, 0, 1, 2, Next